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Background: The small round cell tumors are a heterogeneous group 
of malignant neoplasms. Immunohistochemistry (IHC) has proven to 
be a significant tool in the identification as well as differentiation of 
tumors which become a diagnostic challenge on the basis of routine 
haematoxylin and eosin (H & E) stain alone. The aim of present study 
was to study the histomorphological spectrum of extranodal malignant 
small round cell tumors and to study the significance of a primary panel 
(LCA, CK, S-100 and Vimentin) and secondary panel of IHC markers 
in differential diagnosis of such tumors. 
Methods: The study was carried out in the Department of Pathology, 
Pt. B.D. Sharma, UHS, Rohtak. A total of 60 cases of malignant small 
round cell tumors were selected for IHC and they were classified and 
categorized accordingly after IHC.  
Results: Out of the 60 cases of malignant small round cell tumors, 
there were 19 cases (31.6%) of small cell carcinoma, 16 cases (26.6%) 
of non Hodgkin lymphoma, 5 cases (8.3%) each of Ewing’s sarcoma 
and PNET, 4 cases (6.7%) of medulloblastoma, 3 cases (5%) each of 
rhabdomyosarcoma and seminoma and 1 case (1.7%) each of 
mesothelioma, neuroblastoma, small cell osteosarcoma, Wilm’s tumor 
and poorly differentiated round cell tumor. 
Conclusion: Immunohistochemistry has played a valuable adjunctive 
role for routine hematoxylin and eosin staining in the adequate and 
accurate categorization of small round cell tumors.  
 
                 Copy Right, IJAR, 2017,. All rights reserved. 
…………………………………………………………………………………………………….... 
Introduction:- 
In histopathology, a small round blue cell tumor is any one of a group of malignant neoplasms that have a 
characteristic appearance under the microscope, i.e. consisting of small round cells that stain blue on routine 
haematoxylin & eosin (H&E) stained sections and have scanty cytoplasm. They typically represent undifferentiated 
cells.
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There is a histological similarity and lack of differentiating features on H&E sections in most of the small round cell 
tumors which makes the definite diagnosis extremely difficult and so immunohistochemical (IHC) and molecular 
studies act as an additional support. Diagnosis can be made in about 80-90% of cases on H&E stained slides coupled 
with IHC. However, in about 15-20% of cases there is still a need for molecular or electron microscopic diagnosis. 
The spectrum of small round cell tumors comprises non-Hodgkin lymphoma (NHL); germ cell tumor; sarcomas 
which further include Ewing’s sarcoma/primitive neuroectodermal tumor (ES/PNET), rhabdomyosarcoma, poorly 
differentiated synovial sarcoma, small cell osteosarcoma and leiomyosarcoma; malignant melanoma (small cell 
variant); blastomas which further include neuroblastoma, Wilm’s tumor (nephroblastoma), hepatoblastoma, 
retinoblastoma and  medulloblastoma; carcinoid tumor; mesothelioma; hybrid oncocytoma; small cell carcinoma; 
desmoplastic small round cell tumor (small cell variant) and merkel cell carcinoma. It is therefore, imperative to 
determine whether the small round cell tumor is epithelial, mesenchymal, neuroendocrine, melanocytic or 
hematopoietic in nature for treatment purposes as well as for the prognostic evaluation of the tumor.
2
  
 
Several monoclonal antibodies have been developed, that detect different epitopes of the antigens which are present 
in the tumor cells. However, there is no antibody which is specific for a single tumor type and the pathologist has to 
judiciously correlate the clinical, radiological and the morphological findings with a panel of immumohistochemical 
(IHC) markers. The immunohistochemical profiling of the tumor may be done according to the anatomical location, 
microscopic features and other aspects of their clinical presentations, which all have a strong influence on the 
relative likelihood of a diagnosis.
3
  
Material And Methods:- 
The present prospective study was conducted in the Department of Pathology, Pt. B. D. Sharma, PGIMS, Rohtak. 
Formalin-fixed, paraffin-embedded sections of all the cases which were diagnosed as small round-cell tumors on 
small biopsies and resected specimens were retrieved from the files of the Department of Pathology, Pt. B. D. 
Sharma, UHS, Rohtak. A total of 60 cases were taken for this study. Haematoxylin and eosin stained sections of all 
the study cases were retrieved to confirm the tissue diagnosis and also the immunohistochemical stained sections 
obtained by using peroxidase anti-peroxidase method were studied to categorise the tumors.
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Inclusion Criteria:-  
Small round cell tumors at all the extranodal sites only were included  in the study. 
 
Exclusion Criteria:-  
Small round cell tumors of the lymph node were excluded from the study. 
 
The primary panel of IHC markers which were used in the study to differentiate and categorise the small round blue 
cell tumors was LCA, CK, S-100 and Vimentin. According to their results, secondary panel of IHC markers were 
applied for further sub-classification of these tumors. The secondary panel of IHC markers included PLAP, CD117, 
CD30, CD20, CD10, CD5, Bcl2, Bcl6, PAX5, CD56, TTF1, P63, CD34, WT1, Tdt, CD79a, EGFR, Vwf, Ki67, 
CD99, EMA, CK, vimentin, myogenin, desmin, S-100, calretinin, NSE, chromogranin and synaptophysin. In the 
present study, weak/moderate/strong staining was considered as positive staining and equivocal staining was 
considered as negative staining. 
 
Results:- 
Out of the 60 cases of extranodal malignant small round cell tumor, the most common tumor was small cell 
carcinoma (19 cases, 31.6%) followed by Non-Hodgkin lymphoma (16 cases, 26.6%). The distribution of the small 
round cell tumors in the present study based on the final histopathological diagnosis is given in Table 1. Among the 
60 cases, 45 (75%) were male patients and 15 (25%) were female patients. In our study, age range of the patients 
was between 2-85 years. Mean age of presentation was 40.8 years. The youngest patient was 2 years old and oldest 
was 85 years of age. Maximum number of cases (n=16, 26.7%) belonged to the age group of 51-60 years. Small cell 
carcinoma cases were seen maximum (n=10) in the age group of 51-60 years, non Hodgkin lymphoma were seen 
maximum (n=5) in 41-50 years. Ewing’s sarcoma cases were predominantly seen in age group of 11-20 years while 
PNET cases were seen in age group of 11-30 years, medulloblastoma in age group of 0-20 years and 
rhabdomyosarcoma were seen in 11-20 years of age. Small cell carcinoma cases (n=19) were seen predominantly in 
males, non Hodgkin lymphoma cases (n=16) were seen to have equal distribution in males and females, Ewing’s 
sarcoma was seen predominantly in males while PNET cases were seen to have a male: female ratio of 1:1.5, 
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rhabdomyosarcoma was seen in males predominantly and rest of the categories seemed to have a male: female ratio 
of 1:1. Each of the tumor was adequately categorized using the appropriate antibody panel.  
 
Table 1:-Distribution of the cases according to the histopathological diagnosis. 
No. Type No. of cases Percentage (%) 
1 Ewing’s sarcoma 5 8.3 
2 Medulloblastoma 4 6.7 
3 Mesothelioma 1 1.7 
4 Neuroblastoma 1 1.7 
5 Non Hodgkin lymphoma 16 26.6 
6 Rhabdomyosarcoma 3 5.0 
7 Seminoma 3 5.0 
8 Small cell carcinoma 19 31.6 
9 Small cell osteosarcoma 1 1.7 
10 Wilm’s tumor 1 1.7 
11 PNET 5 8.3 
12 Poorly differentiated round cell tumor 1 1.7 
 Total 60 100.0 
 
In the present study, 36.6 % (n=22) of the cases were diagnosed with the help of morphological features, clinical 
history, location of the tumor and primary panel of IHC markers; although secondary panel was applied for all these 
cases for their further typing, while 61.7 % (n=37) cases required the further application of secondary panel of IHC 
markers for making a definitive diagnosis. Only 1.7 % (n=1) cases were there which were inconclusive even after 
the application of secondary panel of IHC markers (Table 2 & 3). 
 
Table 2:-Cases diagnosed on the basis of primary panel of IHC markers. 
Morphology Location Primary panel of IHC marker Final diagnosis No of 
cases 
% 
CK Vimentin S-100 LCA 
Small round 
cell 
Extranodal 
variable 
sites 
Neg Neg Neg Pos Non Hodgkin 
lymphoma 
16 72.8 
Small round 
cell 
Kidney Pos Pos Neg Neg Wilm’s tumor 1 4.5 
Small round 
cell 
Posterior 
fossa 
Neg Neg Neg Neg Medulloblastoma 4 18.2 
Small round 
cell 
Right 
clavicular 
mass 
Pos Pos Neg Neg Small cell 
osteosarcoma 
1 4.5 
Total       22 100.0 
 
Table 3:-Cases diagnosed on the basis of application of secondary panel of IHC markers.  
Morphology Primary panel of IHC marker Secondary panel 
of IHC marker 
Final diagnosis No. 
of 
cases 
% 
CK Vimentin S-
100 
LCA 
Small round 
cell 
Pos Neg Neg Neg Positive for 
Synaptophysin/ 
NSE/          
Chromogranin/ 
CD56/ TTF1/ P63/ 
EGFR 
Small cell carcinoma 19 51.4 
Small round 
cell 
Pos Neg Neg Neg Calretinin/WT1 Mesothelioma 1 2.7 
Small round 
cell 
Pos Neg Neg Neg PLAP/ CD117 Germ cell tumor 3 8.1 
Small round Neg Pos Neg Neg CD99/ PAS/ Ewing’s sarcoma 5 13.5 
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cell CD117 
Small round 
cell 
Neg Pos Neg Neg Desmin 
/myogenin 
Rhabdomyosarcoma 3 8.1 
Small round 
cell 
Neg Pos Neg Neg CD99 PNET 5 13.5 
Small round 
cell 
Neg Neg Pos Neg NSE/ 
Chromogranin 
Neuroblastoma 1 2.7 
Total       37 100.0 
 
Discussion:- 
Differential diagnosis of small round cell tumors, frequently constitutes a difficult diagnostic problem. Accurate 
diagnosis of these tumors is essential because the treatment options, responses to therapy and prognosis vary widely 
depending on the diagnosis. A careful examination of the H & E sections of the well sampled tumors along with the 
clinical history, anatomical site and radiological findings can be coupled with a suitable panel of IHC markers and 
all these can be integrated to arrive at a conclusive diagnosis. Immunohistochemistry should always be used as an 
adjunct to the morphology, to avoid an erroneous diagnosis. This prospective study was conducted in the 
Department of Pathology, Pt. B.D. Sharma, UHS, Rohtak with the aim to study the histomorphological spectrum of 
extranodal malignant small round cell tumors and to study the significance of primary panel and secondary panel of 
immunohistochemical markers in the diagnosis and categorization of small round cell tumors.  The study group 
included 60 cases of extranodal malignant small round cell tumors. 
 
In our study, age range of the patients was between 2-85 years. Mean age of presentation was 40.8 years. The 
youngest patient was 2 years old and oldest was 85 years of age. Maximum number of cases 16 (26.7%) belonged to 
the age group of 51-60 years. In the study conducted by Bhagat et al
5
, out of 50 cases, maximum number of cases 
were in the age group of 41-50 years (28%) and their ages ranged from 3-80 years with the mean age of 40 years. 
Likewise, the sex distribution and male:female ratio in our study was in concordance with various studies conducted 
before by Ashraf et al
6
, Bhagat et al
7, D’Cruze et al8 and Patel RG et al9. The present study, as well as, most of the 
previous studies show that males are affected more commonly than females. 
 
Our study was in concordance with the study conducted by Ashraf et al
6 
in that the maximum number of cases were 
of small cell carcinoma (19.4%) followed by non Hodgkin lymphoma cases (16.7%). But studies conducted by Patel 
RG et al
9
. Patel A et al
10
, Patel MM et al
11, D’Cruze et al8 and Bashyal et al2 on malignant small round cell tumors 
showed maximum incidence of non Hodgkin lymphoma. This was probably, because they have included nodal as 
well as extranodal cases of non Hodgkin lymphoma in their studies while in the present study, only extranodal NHL 
cases were included and nodal NHL cases were excluded from the present study.   
 
In the present study, small cell carcinoma (n=19, 31.6%) constituted the most predominant type of malignant small 
round cell tumor with the respiratory tract being the most common site (17 cases). The second most common type of 
extranodal malignant small round cell tumor were the non Hodgkin lymphoma cases (n=16, 26.6%) with stomach (3 
cases) as the most common site. Our study was in concordance with the study conducted by Pity IS
12
 in that the 
most common site of  malignant small round cell tumor in their study was also the respiratory tract (n=30, 23.6%). 
In the study conducted by Patel A et al
10
, the most common site of extranodal non Hodgkin lymphoma was also 
stomach, which is in agreement with our study.   
 
In the present study, 24 out of 60 cases were CK positive on primary panel which were then subjected to secondary 
panel of IHC markers. Among these, 19 cases were positive for synaptophysin, chromogranin, NSE, CD56 and p63 
and were diagnosed as small cell carcinoma. Rest of the CK positive cases included 2 cases which were positive for 
PLAP and CD117 and, so were diagnosed as germ cell tumor; 1 case of mesothelioma which showed positivity for 
calretinin and WT1; 1 case which was positive for vimentin, WT1 and desmin was diagnosed as Wilm’s tumor and 
1 case of small cell osteosarcoma which showed positive expression on application of vimentin, CD99 and CD117. 
Although the diagnosis of Wilm’s tumor and small cell osteosarcoma was made on the basis of morphology, 
location of the tumor, age, clinical features and primary panel of IHC markers but other IHC markers were applied 
to confirm the diagnosis. In a study conducted by Patel MM et al
11
, Patel RG et al
9
, Patel A et al
10, D’Cruze et al8 
and Pity IS
12
 they found that 100% cases of Wilm’s tumor were positive for CK, vimentin and WT1, thus correlating 
with our study. Patel MM et al
11
, Patel A et al
10
 and Pity IS
12
  showed 100% cases of seminoma to be PLAP and 
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CD117 positive, thus in concordance with the present study. Also, they showed 92% cases of mesothelioma to be 
positive for calretinin, thus correlating with our study.  
 
In our study, 13 cases out of a total of 60 cases were vimentin positive. On applying secondary panel of IHC 
markers, 8 of these were positive for CD99 and were diagnosed as Ewing’s sarcoma/PNET. Rest of the vimentin 
positive cases included 3 cases of rhabdomyosarcoma which showed positivity for desmin and myogenin and 1 case 
each of small cell osteosarcoma and Wilm’s tumor. Konrad P et al13 showed 94.7% cases and Bashyal et al2 and 
Patel MM et al
11 showed 100% cases of Ewing’s sarcoma/ PNET to be positive for CD99, correlating with our 
study. Immunohistochemically, strong membrane staining for CD99 is consistently seen in almost all cases of 
Ewing’s sarcoma/ PNET, although it is not very specific because it may also come positive in several other soft 
tissue sarcomas and lymphoblastic lymphomas.
2 
Konrad P et al
13
, Patel RG et al
9
, Patel A et al
10
, Ashraf et al
6
, Patel 
MM et al
11, D’Cruze et al8 and Bashyal et al2 showed 100% cases of rhabdomyosarcoma to be positive for myogenin 
which correlates with our study. Vimentin positive cases of blastoma were further divided according to site and 
immunohistochemical profile. Nephroblastoma is the most common paediatric renal neoplasm. In the present study, 
1 case of nephroblastoma was found to be positive for CK, vimentin and WT1. Patel MM et al
11
 found 100% cases 
of Wilm’s tumor to be positive for CK and vimentin, correlating with our study. 
 
There were only 2 cases out of the 60 cases which were S-100 positive, one of these was positive for NSE and 
chromogranin but was negative for CD99 and so, was diagnosed as neuroblastoma whereas the other case was also 
vimentin positive and remained inconclusive despite application of multiple markers. Neuroblastoma shows 
immunoreactivity with NSE, synaptophysin and chromogranin.
2
 Our findings are consistent with the study 
conducted by Patel MM et al
11
.  
 
In the present study, there were 16 cases which were positive for LCA (CD45) out of the 60 cases of extranodal 
malignant small round cell tumors and a diagnosis of NHL was made based on the morphological features and LCA 
positivity. But secondary panel was applied for further typing of the NHL cases. Among these, 13 (81.3%) non 
Hodgkin lymphoma cases were positive for CD20, CD10, Bcl6 and were typed as B-cell NHL while 3 cases 
(18.7%) were positive for CD5 and Tdt and were typed as T-cell NHL. CD45 (LCA) is a surface antigen expressed 
by virtually all hematolymphoid proliferations and monoclonal antibodies for this marker are reliably specific.
2
 Our 
study was in concordance with Konrad P et al
13
, Patel RG et al
9
, Patel A et al
10
, Ashraf et al
6
, Patel MM et al
11
, 
D’Cruze et al8, Pity IS12 and Bashyal et al2. Our study and the previous studies showed that NHL cases show 100% 
positive expression for LCA and B-cell lymphomas are more common than T-cell lymphoma. 
 
Table 4:-Comparision of various studies where IHC contributed to the diagnosis:- 
Study group Total cases in which 
IHC was applied 
Diagnosis on IHC  Percentage of 
diagnosed cases (%) 
Percentage of 
inconclusive cases 
(%) 
Shah et al
14 
56 49 87.5 12.5 
Ahmed et al
15 
265 249 93.9 6.1 
Pity IS
12 
127 112 88.2 11.8 
Bashyal et al
2 
40 36 90 10 
Bhagat et al
7 
50 49 98 2 
D’Cruze et al8 40 40 100 0 
Patel MM et al
11 
80 77 96.3 3.7 
Bhagat et al
5 
74 73 98.6 1.4 
Ashraf et al
6 
36 33 91.7 8.3 
Patel A et al
10 
38 37 97.4 2.6 
Present study 60 59 98.3 1.7 
 
Our study was in concordance with the study conducted by Bhagat et al
5, D’Cruze et al8, Patel MM et al11, Ahmed et 
al
15
, Patel A et al
10 
and Ashraf et al
6
 (Table 4). So our study is well supported and shows the vital role of IHC in the 
differential diagnosis of extranodal malignant small round cell tumors. The studies conducted by Shah et al
14
 and 
Pity IS
12
 showed a slightly higher proportion of cases which were left inconclusive even after IHC application 
(12.5% and 11.8% respectively). This could be probably, because of a limited number of IHC markers employed in 
their studies, limitations of the technique employed, antigen changes during tissue fixation or true absence of 
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cellular differentiation, while the panel of IHC markers was exhaustive in rest of the studies. In cases, which are 
rendered inconclusive on morphology and IHC; electron microscopy, cytogenetic studies and molecular techniques 
may be helpful. These were out of scope in our present study because of their non-availability in our set-up. 
 
Immunohistochemistry has emerged as a very valuable diagnostic tool to help in distinguishing the undifferentiated 
tumors especially small round cell tumors. Its advantages include its remarkable sensitivity and specificity, its 
applicability to routinely processed, formalin fixed material and compatibility to most of the common fixatives. 
Proper panel of IHC markers followed according to the guidelines is very useful which specifically saves both, 
tissue and time for the correct diagnosis and further typing. In some of the cases, IHC markers do not discriminate 
between neoplastic and non-neoplastic lesions. The distinction in such cases has to be made by conventional 
histopathological morphology which is must as a primary screening for all the cases. The immunohistochemistry 
needs to be applied routinely for undifferentiated tumors in the diagnostic histopathology. This, of course, needs to 
be supplemented by the use of cytogenetic studies such as fluorescent in situ hybridization (FISH) whenever 
required and available with a firm realization that all these are invaluable adjuncts to meticulous gross and 
microscopic examination, but cannot replace them.  
 
Conclusion:-  
The small round cell tumors are a heterogeneous group of malignant neoplasms. Immunohistochemistry represents a 
cost effective and rapid tool that can provide us a clear distinction among the various types of small round cell 
tumors. Its purpose is to categorise the patients so that an appropriate and a specific treatment can be ensured, as 
well as to identify those cases which are at a higher risk of recurrence and fatal outcomes, so that timely measures 
can be taken. A panel approach which comprises of carefully selected antibodies should always be there, so that an 
antigenic profile of positive as well as negative markers can be made and this will provide the most accurate 
characterization of tumor. Our study showed that the use of immunohistochemistry was extremely beneficial in the 
categorization of small round cell tumors. It must be performed at a high standard, so that the results are meaningful 
and reproducible. Molecular techniques and electron microscopy should be integrated selectively in future at the 
discretion of the pathologist to provide rapid and comprehensive solutions for inconclusive cases.  
                                    
Figure:-1a                                                       Figure:-1b 
Figure 1a:-A case of small cell carcinoma arising from the respiratory tract, showing hyperchromatic small round 
tumor cells. (H&E,200X) 
Figure 1b:-Small cell carcinoma showing positive expression of synaptophysin in tumor cells. (IHC, 200X) 
 
  
Figure:-2a                                                       Figure:-2b 
Figure 2a:-A case of Lymphoblastic lymphoma (T-cell type) presenting as a mediastinal mass. (H&E, 200X) 
Figure 2b:-Lymphoblastic lymphoma, T-cell type showing positive expression of Tdt. (IHC, 200X) 
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Figure 3a                                                       Figure 3b 
 Figure 3a:-A case of extranodal non Hodgkin lymphoma (NHL) showing hyperchromatic small round cells. 
(H&E,200X) 
Figure 3b:-Case of NHL, B-cell type, showing positive CD20 expression. (IHC, 200X) 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
               
Figure:-4a                                                        Figure:-4b 
Figure 4a:-Ewing’s sarcoma showing cells with uniform round nuclei. (H&E, 200X) 
Figure 4b:-Ewing’s sarcoma showing positive expression of CD99 in tumor cells. (IHC, 200X) 
 
 
Figure:-5a                                                       Figure:-5b 
Figure 5a:-Medulloblastoma presenting as posterior fossa mass showing small round tumor cells. (H&E, 200X) 
Figure 5b:-Medulloblastoma showing GFAP (Glial Fibrillary Acidic Protein) positive expression in tumor cells. 
(IHC, 200X) 
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Figure:-6a                                                       Figure:-6b 
Figure 6a:-A case of seminoma involving left side testes, showing malignant small round tumor cells. (H&E,200X) 
Figure 6b:-Case of seminoma showing positive expression of PLAP in tumor cells. (IHC, 200X) 
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